ClearBridge Investments, an investment management company, released its “ClearBridge Select Strategy” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. U.S. equities strongly rebounded in the second quarter. The S&P 500 Index returned 10.9%, and the benchmark Russell 3000 Index advanced 11.0%, as risk-on sentiment took hold following the pause in tariff implementation. The strategy outperformed the benchmark in the quarter, driven by the strength in portfolio construction acr ...

ClearBridge Investments, an investment management company, released its “ClearBridge Select Strategy” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. U.S. equities strongly rebounded in the second quarter. The S&P 500 Index returned 10.9%, and the benchmark Russell 3000 Index advanced 11.0%, as risk-on sentiment took hold following the pause in tariff implementation. The strategy outperformed the benchmark in the quarter, driven by the strength in portfolio construction acr ...

NEW YORK, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against RxSight, Inc. (NASDAQ: RXST) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in RxSight, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/rxsight-inc-class-action-lawsuit. Investors have until September 22, 2025, to ask the Court to ...

RA'ANANA, Israel, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. IINN ("Inspira," "Inspira Technologies," or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced it will present its HYLA blood sensor ("HYLA") to the global medical community for the first time. The presentation will take place at the U.S. ELSO Annual Conference in Washington, D.C., between September 27–30, 2025.This official unveiling follows the Company's recent announce ...

RA'ANANA, Israel, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira," “Inspira Technologies,” or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced it will present its HYLA blood sensor (“HYLA”) to the global medical community for the first time. The presentation will take place at the U.S. ELSO Annual Conference in Washington, D.C., between September 27–30, 2025. This official unveiling follows the Company’s rece ...

公司战略调整 - 医疗设备制造商GE Healthcare正与顾问合作探索出售其中国部门部分股权的选项 [1] 市场动态 - 该举措显示跨国公司可能正在调整其在中国市场的投资和运营策略 [1]

AVITA Medical, Inc. (NASDAQ: RCEL ) is a company working on a complete portfolio for full-thickness wound reconstruction. They offer RECELL and RECELL GO for point-of-care autologous “Spray-On Skin.” RCEL also has Cohealyx for graft-ready dermis, and PermeaDerm as a protective biosynthetic cover in partnershipMy name is Myriam Hernandez Alvarez. I received the Electronics and Telecommunication Engineering degree from the Escuela Politecnica Nacional, Quito, Ecuador, the M.Sc. degree in computer science from ...

AVITA Medical, Inc. (NASDAQ: RCEL ) is a company working on a complete portfolio for full-thickness wound reconstruction. They offer RECELL and RECELL GO for point-of-care autologous “Spray-On Skin.” RCEL also has Cohealyx for graft-ready dermis, and PermeaDerm as a protective biosynthetic cover in partnershipMy name is Myriam Hernandez Alvarez. I received the Electronics and Telecommunication Engineering degree from the Escuela Politecnica Nacional, Quito, Ecuador, the M.Sc. degree in computer science from ...

公司业务与商业模式 - RxSight是一家商业阶段医疗技术公司 专注于白内障治疗领域 其核心产品为RxSight Light Adjustable Lens系统 包括可调节人工晶体（LAL）和光传输设备（LDD）[3] - 公司采用"剃须刀/刀片"商业模式 通过扩大高单价LDD设备的装机量来驱动重复性、高利润的LAL手术量增长[3] 诉讼指控内容 - 指控公司在2024年5月7日至2025年7月8日期间虚假宣称装机基地使用率"全面提升" 且新客户群体采用速度与早期客户相当或更快[4] - 指控公司实地团队组织架构存在缺陷且表现不佳 新客户群体需要更多支持且采用速度较慢 装机基地整体使用率实际上处于下降趋势[4] - 指控公司增量LDD设备投放未能转化为预期LAL手术量 严重破坏了公司的增长模式[4] 股价重大变动事件 - 2025年4月2日公司披露季度LAL销售额环比下降 并将全年收入指引下调约2400万美元 导致股价单日下跌约38%[5] - 2025年7月8日公司进一步披露LDD销售额环比暴跌45% LAL销售额连续第二个季度下降 承认新客户需要更多支持且采用速度较慢 股价再次下跌约38%[6] 法律程序信息 - 集体诉讼案件编号为Gémesi v RxSight, Inc, No 25-cv-02093 此前另有案件Makaveev v RxSight, Inc, No 25-cv-01596[1] - 主导原告动议必须在2025年9月22日前向法院提交 投资者可通过指定链接或电话800/449-4900联系律师事务所[2][8]

Owning promising growth stocks over the long term is a surefire way for you to build your wealth towards a happy retirement.There is a plethora of investment choices in the US market where you can find many growth stocks in various sectors.To build a sturdy growth stock portfolio, you should select companies that possess a robust economic moat and boast strong growth track records.Here are four US stocks you can consider owning for the long term.Palo Alto Networks (NASDAQ: PANW)Palo Alto Networks, or PAN, p ...